{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:41:15Z","timestamp":1792698075451,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"DOI":"10.1007\/s00234-026-04223-1","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:41:32Z","timestamp":1792651292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Imaging features of pituitary Crooke cell adenoma: a 13-case series"],"prefix":"10.1007","author":[{"given":"Yi","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0737-3646","authenticated-orcid":false,"given":"Lei","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4260-756X","authenticated-orcid":false,"given":"Lixia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"4223_CR1","doi-asserted-by":"crossref","unstructured":"Asa SL, Perry A (2020) Tumors of the Pituitary Gland. American Registry of Pathology","DOI":"10.55418\/9781933477916"},{"issue":"1","key":"4223_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr Pathol Mar 33(1):6\u201326. https:\/\/doi.org\/10.1007\/s12022-022-09703-7","journal-title":"Endocr Pathol Mar"},{"issue":"2","key":"4223_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11154-019-09534-8","volume":"21","author":"C Tatsi","year":"2020","unstructured":"Tatsi C, Stratakis CA (2020) Aggressive pituitary tumors in the young and elderly. Rev Endocr Metab Disord Jun 21(2):213\u2013223. https:\/\/doi.org\/10.1007\/s11154-019-09534-8","journal-title":"Rev Endocr Metab Disord Jun"},{"key":"4223_CR4","doi-asserted-by":"publisher","first-page":"1468727","DOI":"10.3389\/fmed.2025.1468727","volume":"12","author":"L Kattah","year":"2025","unstructured":"Kattah L, Bustamante L, Sanabria D, Salazar J (2025) Case Report: Refractory hypokalemia as a clinical manifestation of Crooke\u2019s cell adenoma. Front Med (Lausanne) 12:1468727. https:\/\/doi.org\/10.3389\/fmed.2025.1468727","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"4223_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11102-025-01566-5","volume":"5","author":"P Kober","year":"2025","unstructured":"Kober P, Szczepaniak M, P\u0119kul M et al (2025) USP8, USP48, BRAF and TP53 mutations in crooke cell adenoma. Pituitary 28(5):107. https:\/\/doi.org\/10.1007\/s11102-025-01566-5","journal-title":"Pituit Oct"},{"key":"4223_CR6","doi-asserted-by":"publisher","first-page":"947085","DOI":"10.3389\/fendo.2022.947085","volume":"13","author":"D Zhu","year":"2022","unstructured":"Zhu D, Wang Z, Tian T et al (2022) Prevalence and clinical characteristics of Crooke\u2019s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review. Front Endocrinol (Lausanne) 13:947085. https:\/\/doi.org\/10.3389\/fendo.2022.947085","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"4223_CR7","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1227\/neu.0000000000000657","volume":"76","author":"A Di Ieva","year":"2015","unstructured":"Di Ieva A, Davidson JM, Syro LV et al (2015) Crooke\u2019s cell tumors of the pituitary. Neurosurg 76(5):616\u2013622. https:\/\/doi.org\/10.1227\/neu.0000000000000657","journal-title":"Neurosurg May"},{"issue":"7","key":"4223_CR8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3760\/cma.j.cn112151-20231208-00397","volume":"8","author":"C Ge","year":"2024","unstructured":"Ge C, Wang Q, Wang W et al (2024) [Pituitary Crooke cell neuroendocrine tumor of adrenocorticotropic hormone differentiation-specific transcription factor lineage: a clinicopathological analysis of six cases]. Zhonghua Bing Li Xue Za Zhi Jul 53(7):722\u2013727. https:\/\/doi.org\/10.3760\/cma.j.cn112151-20231208-00397","journal-title":"Zhonghua Bing Li Xue Za Zhi Jul"},{"key":"4223_CR9","doi-asserted-by":"publisher","unstructured":"Todnem N, Ward A, Segar S, Rojiani AM, Rahimi SY (2018) Clinically silent adrenocorticotropic hormone\u2013positive Crooke cell adenoma: case report and review of literature. World Neurosurg Nov 119:197\u2013200. https:\/\/doi.org\/10.1016\/j.wneu.2018.07.233","DOI":"10.1016\/j.wneu.2018.07.233"},{"key":"4223_CR10","doi-asserted-by":"publisher","unstructured":"Giraldi EA, Neill SG, Mendoza P, Saindane A, Oyesiku NM, Ioachimescu AG (2022) Functioning Crooke cell adenomas: case series and literature review. World Neurosurg Feb 158:e754\u2013e765. https:\/\/doi.org\/10.1016\/j.wneu.2021.11.049","DOI":"10.1016\/j.wneu.2021.11.049"},{"key":"4223_CR11","doi-asserted-by":"publisher","unstructured":"Zhang S, Luo W (2026) Pituitary crooke cell adenoma presenting with isolated visual impairment as the initial Symptom. J Craniofac Surg May 15. https:\/\/doi.org\/10.1097\/scs.0000000000012379","DOI":"10.1097\/scs.0000000000012379"},{"issue":"10","key":"4223_CR12","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1097\/00000478-200310000-00005","volume":"27","author":"DH George","year":"2003","unstructured":"George DH, Scheithauer BW, Kovacs K et al (2003) Crooke\u2019s cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol Oct 27(10):1330\u20131336. https:\/\/doi.org\/10.1097\/00000478-200310000-00005","journal-title":"Am J Surg Pathol Oct"},{"issue":"2","key":"4223_CR13","first-page":"214","volume":"116","author":"PE Neumann","year":"1984","unstructured":"Neumann PE, Horoupian DS, Goldman JE, Hess MA (1984) Cytoplasmic filaments of Crooke\u2019s hyaline change belong to the cytokeratin class. An immunocytochemical and ultrastructural study. Am J Pathol Aug 116(2):214\u2013222","journal-title":"Am J Pathol Aug"},{"key":"4223_CR14","doi-asserted-by":"publisher","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. Oct 33(4):610\u2013617; discussion 617\u2013618. https:\/\/doi.org\/10.1227\/00006123-199310000-00008","DOI":"10.1227\/00006123-199310000-00008"},{"issue":"4","key":"4223_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/bf00593265","volume":"36","author":"S Kobayashi","year":"1994","unstructured":"Kobayashi S, Ikeda H, Yoshimoto T (1994) A clinical and histopathological study of factors affecting MRI signal intensities of pituitary adenomas. Neuroradiol 36(4):298\u2013302. https:\/\/doi.org\/10.1007\/bf00593265","journal-title":"Neuroradiol May"},{"issue":"1","key":"4223_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/rct.0000000000001249","volume":"01","author":"CX Liu","year":"2022","unstructured":"Liu CX, Wang SZ, Heng LJ et al (2022) Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics. J Comput Assist Tomogr Jan-Feb 46(1):124\u2013130. https:\/\/doi.org\/10.1097\/rct.0000000000001249","journal-title":"J Comput Assist Tomogr Jan-Feb"},{"issue":"1","key":"4223_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1148\/radiology.177.1.2399335","volume":"177","author":"Y Miki","year":"1990","unstructured":"Miki Y, Matsuo M, Nishizawa S et al (1990) Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging. Radiology 177(1):35\u201338. https:\/\/doi.org\/10.1148\/radiology.177.1.2399335","journal-title":"Radiol Oct"},{"issue":"5","key":"4223_CR18","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1210\/clinem\/dgab901","volume":"107","author":"MR Gadelha","year":"2022","unstructured":"Gadelha MR, Barbosa MA, Lamback EB, Wildemberg LE, Kasuki L, Ventura N (2022) Pituitary MRI standard and advanced sequences: role in the diagnosis and characterization of pituitary adenomas. J Clin Endocrinol Metab 107(5):1431\u20131440. https:\/\/doi.org\/10.1210\/clinem\/dgab901","journal-title":"J Clin Endocrinol Metabolism"},{"key":"4223_CR19","doi-asserted-by":"publisher","first-page":"108931","DOI":"10.1016\/j.ejrad.2020.108931","volume":"126","author":"A Yao","year":"2020","unstructured":"Yao A, Rutland JW, Verma G et al (2020) Pituitary adenoma consistency: Direct correlation of ultrahigh field 7T MRI with histopathological analysis. Eur J Radiol May 126:108931. https:\/\/doi.org\/10.1016\/j.ejrad.2020.108931","journal-title":"Eur J Radiol May"},{"issue":"3","key":"4223_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11102-020-01122-3","volume":"24","author":"Y Fang","year":"2021","unstructured":"Fang Y, Pei Z, Chen H et al (2021) Diagnostic value of Knosp grade and modified Knosp grade for cavernous sinus invasion in pituitary adenomas: a systematic review and meta-analysis. Pituitary 24(3):457\u2013464. https:\/\/doi.org\/10.1007\/s11102-020-01122-3","journal-title":"Pituit Jun"},{"key":"4223_CR21","doi-asserted-by":"publisher","unstructured":"Araujo-Castro M, Acitores Cancela A, Vior C, Pascual-Corrales E, Rodr\u00edguez Berrocal V (2022) Radiological Knosp, Revised-Knosp, and Hardy\u2013Wilson classifications for the prediction of surgical outcomes in the endoscopic endonasal surgery of pituitary adenomas: study of 228 cases. Front Oncol Jan 11:807040. https:\/\/doi.org\/10.3389\/fonc.2021.807040","DOI":"10.3389\/fonc.2021.807040"},{"issue":"4","key":"4223_CR22","doi-asserted-by":"publisher","first-page":"E533","DOI":"10.1227\/neu.0000000000001389","volume":"79","author":"JW Lucas","year":"2016","unstructured":"Lucas JW, Bodach ME, Tumialan LM et al (2016) Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Primary Management of Patients With Nonfunctioning Pituitary Adenomas. Neurosurg 79(4):E533\u2013535. https:\/\/doi.org\/10.1227\/neu.0000000000001389","journal-title":"Neurosurg Oct"},{"issue":"1","key":"4223_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12902-025-02115-8","volume":"26","author":"Y Chen","year":"2025","unstructured":"Chen Y, Yang Y, Zhang H, Feng T, Wei L, Wang S (2025) Clinical, radiological, and pathological characteristics and long-term outcomes of silent corticotroph adenomas: a retrospective study. BMC Endocr Disord Dec 1 26(1):6. https:\/\/doi.org\/10.1186\/s12902-025-02115-8","journal-title":"BMC Endocr Disord Dec 1"},{"issue":"12","key":"4223_CR24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/s2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol Dec 9(12):847\u2013875. https:\/\/doi.org\/10.1016\/s2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol Dec"},{"issue":"1","key":"4223_CR25","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1210\/clinem\/dgaa773","volume":"106","author":"F Wang","year":"2021","unstructured":"Wang F, Catalino MP, Bi WL et al (2021) Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease. J Clin Endocrinol Metab 106(1):e94\u2013e102. https:\/\/doi.org\/10.1210\/clinem\/dgaa773","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"6","key":"4223_CR26","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3171\/2020.10.Jns203236","volume":"135","author":"BA Strickland","year":"2021","unstructured":"Strickland BA, Shahrestani S, Briggs RG et al (2021) Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence. J Neurosurg Dec 1 135(6):1706\u20131713. https:\/\/doi.org\/10.3171\/2020.10.Jns203236","journal-title":"J Neurosurg Dec 1"},{"key":"4223_CR27","doi-asserted-by":"publisher","unstructured":"Nieman LK, Biller BM, Findling JW et al (2015) Treatment of cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 100(8):2807\u20132831. https:\/\/doi.org\/10.1210\/jc.2015-1818","DOI":"10.1210\/jc.2015-1818"},{"issue":"7","key":"4223_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/pai.0000000000001070","volume":"1","author":"RY Osamura","year":"2023","unstructured":"Osamura RY, Inomoto C, Tahara S, Oyama KI, Matsuno A, Teramoto A (2023) Pathology of Crooke Cells in the Human Pituitaries: A Timely Review. Appl Immunohistochem Mol Morphol Aug 31(7):485\u2013489. https:\/\/doi.org\/10.1097\/pai.0000000000001070","journal-title":"Appl Immunohistochem Mol Morphol Aug"},{"key":"4223_CR29","doi-asserted-by":"publisher","unstructured":"Dogansen SC, Yalin GY, Tanrikulu S et al (2018) Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas. Pituitary 21(4):347\u2013354. https:\/\/doi.org\/10.1007\/s11102-018-0877-3","DOI":"10.1007\/s11102-018-0877-3"},{"issue":"3","key":"4223_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12022-024-09819-y","volume":"35","author":"ET Durmu\u015f","year":"2024","unstructured":"Durmu\u015f ET, Kefeli M, Mete O et al (2024) Granulation Patterns of Functional Corticotroph Tumors Correlate with Tumor Size, Proliferative Activity, T2 Intensity-to-White Matter Ratio, and Postsurgical Early Biochemical Remission. Endocr Pathol Sep 35(3):185\u2013193. https:\/\/doi.org\/10.1007\/s12022-024-09819-y","journal-title":"Endocr Pathol Sep"},{"key":"4223_CR31","doi-asserted-by":"publisher","unstructured":"Cazabat L, Dupuy M, Boulin A et al (2014) Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas. Clin Endocrinol (Oxf) 81(4):566\u2013572. https:\/\/doi.org\/10.1111\/cen.12443","DOI":"10.1111\/cen.12443"},{"issue":"2","key":"4223_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/cen.14133","volume":"92","author":"L Kasuki","year":"2020","unstructured":"Kasuki L, Antunes X, Coelho MCA et al (2020) Accuracy of microcystic aspect on T2-weighted MRI for the diagnosis of silent corticotroph adenomas. Clin Endocrinol (Oxf) Feb 92(2):145\u2013149. https:\/\/doi.org\/10.1111\/cen.14133","journal-title":"Clin Endocrinol (Oxf) Feb"},{"key":"4223_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-3-7091-9183-5_12","volume":"53","author":"E Knosp","year":"1991","unstructured":"Knosp E, Kitz K, Steiner E, Matula C (1991) Pituitary adenomas with parasellar invasion. Acta Neurochir Suppl (Wien) 53:65\u201371. https:\/\/doi.org\/10.1007\/978-3-7091-9183-5_12","journal-title":"Acta Neurochir Suppl (Wien)"},{"issue":"4","key":"4223_CR34","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3171\/2014.12.Jns141083","volume":"122","author":"AS Micko","year":"2015","unstructured":"Micko AS, W\u00f6hrer A, Wolfsberger S, Knosp E (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J Neurosurg Apr 122(4):803\u2013811. https:\/\/doi.org\/10.3171\/2014.12.Jns141083","journal-title":"J Neurosurg Apr"},{"key":"4223_CR35","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.wneu.2020.02.137","volume":"138","author":"GM Cortez","year":"2020","unstructured":"Cortez GM, Monteiro A, Agnoletto G, Bit-Ivan EN, Sauvageau E, Hanel RA (2020) Aggressive Pituitary Tumor with Crooke\u2019s Cells and Invasion of the Posterior Fossa. World Neurosurg Jun 138:530\u2013534.e1. https:\/\/doi.org\/10.1016\/j.wneu.2020.02.137","journal-title":"World Neurosurg Jun"},{"issue":"3","key":"4223_CR36","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1007\/s12020-024-03877-2","volume":"85","author":"E Lefevre","year":"2024","unstructured":"Lefevre E, Chasseloup F, Hage M, Chanson P, Buchfelder M, Kamenick\u00fd P (2024) Clinical and therapeutic implications of cavernous sinus invasion in pituitary adenomas. Endocrine 85(3):1058\u20131065. https:\/\/doi.org\/10.1007\/s12020-024-03877-2","journal-title":"Endocr Sep"},{"issue":"6","key":"4223_CR37","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvaf100","volume":"192","author":"G Raverot","year":"2025","unstructured":"Raverot G, Burman P, Abreu AP et al (2025) Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas. Eur J Endocrinol 192(6):G1\u2013G34. https:\/\/doi.org\/10.1093\/ejendo\/lvaf100","journal-title":"Eur J Endocrinol"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-026-04223-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-026-04223-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-026-04223-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:01:53Z","timestamp":1792695713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-026-04223-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":37,"alternative-id":["4223"],"URL":"https:\/\/doi.org\/10.1007\/s00234-026-04223-1","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"17 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}